Navigation Links
Quincy Bioscience Sponsors Multiple Sclerosis (MS) Scholarship Program
Date:6/17/2010

Quincy Bioscience is pleased to be a sponsor of the annual fundraising MS Luncheons held in Wisconsin which help support families affected by MS and to be a corporate contributor to the MS Scholarship Program. Quincy Bioscience recently launched MS HOPE Trials which will investigate how its patented calcium-binding technology may help improve the quality of life for those with MS.

Madison, WI (Vocus) June 17, 2010 -- Quincy Bioscience is pleased to be a sponsor of the annual MS Luncheons held in Milwaukee and Madison and to be a corporate contributor to the MS Scholarship Program. The MS Luncheon is an annual fundraising event which showcases how donor support moves research forward and meets urgent needs in Wisconsin.

Quincy Bioscience has recently launched the MS HOPE Trial investigating how its patented calcium-binding technology may help improve the quality of life for those with MS at MS HOPE Trials.

The theme of the luncheon fundraisers is “My Cause. My Cure. My Commitment…to a world free of MS.” Funds raised through the luncheon support ground-breaking research into the cause, care and cure of MS, and services designed to address the challenges of living with MS.

The MS Scholarship Program was created to assist in making college dreams a reality for people with MS or their children, who are pursuing a post-secondary education and have demonstrated leadership, academic excellence and financial need.

“Living with MS can be incredibly challenging. The MS Luncheons create awareness and help support those diagnosed with MS as well as their families. Quincy Bioscience is working diligently to improve the outcomes of those with Multiple Sclerosis,” explains Mark Underwood, President of Quincy Bioscience.

About Quincy Bioscience
Quincy Bioscience is a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company's products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms.

###

Read the full story at http://www.prweb.com/releases/multiplesclerosis/hopetrials/prweb4152014.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Quincy Bioscience Launches HOPETrials.com; Research Studies More Accessible For Participants
2. Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of Alex Leaf Distinguished Scientist Award
3. Martek Biosciences and the National Center for Creative Aging Introduce New Brain Health Awareness Campaign, "Beautiful Minds: Finding Your Lifelong Potential"
4. Exalenz Bioscience Expands Market Coverage for the BreathID Breath Test System
5. Digital Pathology Services Firm Flagship Biosciences Appoints New CEO
6. Southridge LLC Provides Equity Capital Through Private Agreement with PuraMed Bioscience
7. Euthymics Bioscience Collaborates with GlobalSign and SafeNet to Provide an FDA Approved Electronic Signature Solution
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2009 Financial Results
9. Synomics Pharma and Bioscience Laboratories Announce Partnership to Provide Topical Clinical Phase 1 Study Services
10. Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership
11. Thriving Bioscience Region Leaves Its Mark
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Quincy Bioscience Sponsors Multiple Sclerosis (MS) Scholarship Program
(Date:3/30/2017)... ... ... inventor and manicurist from Greet, S.C., wants to offer people a new way to care ... and healthy feet, so I know the importance of proper foot care," he said. "In ... FOOT-TRAN SYSTEM." , The FOOT-TRAN SYSTEM enables a user to clean and exfoliate the bottoms ...
(Date:3/30/2017)... ... 30, 2017 , ... This morning, more than 275 medical ... support for an independent Vaccine Safety Commission. Five of the signers of the ... hold a press conference at 9:00 AM Friday, March 31 at the ...
(Date:3/29/2017)... San Diego, CA (PRWEB) , ... March 29, 2017 , ... ... meningiomas(1,2), and up to 300,000 people each year develop other types of metastatic brain ... spread quickly throughout the brain(3). As efforts focus on finding more effective treatment options, ...
(Date:3/29/2017)... ... ... main cause of hay fever in the United States, with an estimated 95 percent of ... July each year; with the worst time for sufferers being June and July. , ... provide an effective defense against grass pollen; they are proven in independent studies to trap ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its ... Life" or "Wonder Spice", it has been used for thousands of years. , "The ... says Heshelow, author of " Turmeric: How to Use it For Your Wellness. Overcome ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... PHILADELPHIA , March 30, 2017  Lannett Company, ... the company voluntarily made a $25 million payment against ... $25 million payment, combined with the $75 million payment ... us approximately $5.5 million in annualized cash interest expense, ... executive officer of Lannett.  "Our business is solid and ...
(Date:3/29/2017)... Research and Markets has announced the addition of the ... (Insource IONM, Outsource IONM), By Region And Trend Analysis From ... ... Intraoperative Neuromonitoring (IONM) market is expected to reach USD 3.6 ... witness significant growth in the forecast period, which can be ...
(Date:3/29/2017)... NEW YORK , March 29, 2017 Global ... cross US$ 3 billion by 2021, growing at a CAGR ... containing iron prescribed by a doctor to treat anemia or ... the iron level in the body. However, in some cases, ... in the body and intravenous (IV) iron therapy comes into ...
Breaking Medicine Technology: